Inventor
SCHLACHTER STEPHEN T
US40 patents
⚠️ This page may combine multiple inventors who share the name “SCHLACHTER STEPHEN T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PELOTON THERAPEUTICS INC
9 patentsUS9908845B2Mar 6, 2018
Aryl ethers and uses thereof
PELOTON THERAPEUTICS INC16 citations92
US10597366B2Mar 24, 2020
Aryl ethers and uses thereof
PELOTON THERAPEUTICS INC4 citations83
US10144711B2Dec 4, 2018
Aryl ethers and uses thereof
PELOTON THERAPEUTICS INC8 citations83
US9969689B2May 15, 2018
Aryl ethers and uses thereof
PELOTON THERAPEUTICS INC8 citations83
US9896418B2Feb 20, 2018
Aryl ethers and uses thereof
PELOTON THERAPEUTICS INC9 citations83
US9884843B2Feb 6, 2018
Cyclic sulfone and sulfoximine analogs and uses thereof
PELOTON THERAPEUTICS INC9 citations83
USRE49948EApr 30, 2024
Aryl ethers and uses thereof
PELOTON THERAPEUTICS INC1 citations72
US10807948B2Oct 20, 2020
Aromatic compounds and uses thereof
PELOTON THERAPEUTICS INC2 citations72
US10040767B2Aug 7, 2018
Benzimidazole derivatives and uses thereof
PELOTON THERAPEUTICS INC0 citations41
ICOS CORP
6 patentsUS6423710B1Jul 23, 2002
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP47 citations95
US6716871B2Apr 6, 2004
Cyclic AMP-specific phosphodie sterase inhibitors
ICOS CORP14 citations92
US6680336B2Jan 20, 2004
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP23 citations92
US6376489B1Apr 23, 2002
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP22 citations92
US6998416B2Feb 14, 2006
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP1 citations62
US7176229B2Feb 13, 2007
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP0 citations51
ARRAY BIOPHARMA INC
6 patentsUS8003651B2Aug 23, 2011
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
ARRAY BIOPHARMA INC35 citations92
US9359340B2Jun 7, 2016
Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors
ARRAY BIOPHARMA INC9 citations83
US9409886B2Aug 9, 2016
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
ARRAY BIOPHARMA INC2 citations61
US8895566B2Nov 25, 2014
5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors
ARRAY BIOPHARMA INC1 citations51
US9328091B2May 3, 2016
5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors
ARRAY BIOPHARMA INC0 citations50
US8987251B2Mar 24, 2015
Triazolopyridine compounds as PIM kinase inhibitors
ARRAY BIOPHARMA INC0 citations36
UPJOHN CO
5 patentsUS6043248AMar 28, 2000
Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase
UPJOHN CO22 citations91
US5981537ANov 9, 1999
Pyrimidine-thioalkyl and alkylether compounds
UPJOHN CO20 citations82
US5397774AMar 14, 1995
Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories
UPJOHN CO17 citations73
US5643895AJul 1, 1997
Phosphonoacetic esters and acids as anti-inflammatories
UPJOHN CO1 citations52
US5565441AOct 15, 1996
Phosphonoacetic esters and acids as anti-inflammatories
UPJOHN CO0 citations52
AMGEN INC
4 patentsUS6022884AFeb 8, 2000
Substituted pyridine compounds and methods of use
AMGEN INC207 citations99
US6458813B1Oct 1, 2002
Substituted pyridine compounds and methods of use
AMGEN INC45 citations96
US6333341B1Dec 25, 2001
Substituted pyridine compounds and methods of use
AMGEN INC31 citations92
US6184237B1Feb 6, 2001
Substituted pyridine compounds and methods of use
AMGEN INC10 citations74
MITCHELL IAN S
3 patentsUS8063050B2Nov 22, 2011
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
MITCHELL IAN S63 citations97
US8853199B2Oct 7, 2014
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
MITCHELL IAN S20 citations92
US8846681B2Sep 30, 2014
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
MITCHELL IAN S11 citations83